Effect of Ilex latifolia Thunb. extract on the adults who complained of memory deterioration for the Efficacy and Safety; A 8week, Randomized, Double-blind, Placebo-Controlled Clinical Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001997

Enrollment

Registered

2016-08-09

Start date

2015-12-09

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Subjects will be randomized to receive Ilex latifolia Thunb. extract tablet 1g or placebo. Subjects will orally self-adminster Ilex latifolia Thunb. extract tablets 1g or placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Subjects who have Brief Cognitive Status Exam score in K-WMS-IV(Korean-Wechsler Memory-Scale-IV) over boundary line and have Auditory Memory score or Visual Memory score below 85.(20>=age>45) 2. Subjects who have decreased SVLT(Seoul Verbal Learning Test) or RCFT(Rey Complex Figure Test) score(-1.0SD=age>=65)

Exclusion criteria

Exclusion criteria: Subject with mental disorders such as schizophrenia, depressive disorder, drug intoxication

Design outcomes

Primary

Measure	Time frame
ADAS-cog(Alzheimer’s Disease Assessment Scale-Korean version-cognitive subscale) Total score ;ADAS-cog(Alzheimer’s Disease Assessment Scale-Korean version-cognitive subscale) memory	—

Secondary

Measure	Time frame
Adverse Event	—

Countries

Korea, Republic of

Contacts

Public ContactPaik Woo

Kyung Hee University Hospital

paikjw@gmail.com

Outcome results